IndiaTickerGennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.BSE · financial results · pdf
Source filing Company dossier
Gennex Laboratories
BSE:GENNEX · ISIN INE509C01026
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Gennex Laboratories
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Gennex Laboratories Ltd - 531739 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Gennex Laboratories Ltd - 531739 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Gennex Laboratories Ltd - 531739 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Financial Result For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Meeting Held On Today I.E. 30Th May 2026BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Notice Convening Extraordinary General Meeting (EGM) To Be Held On Tuesday, May 12, 2026 Through VC And OAVMBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Revised OutcomeBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for For Meeting Held On April 16, 2026 Of Gennex Laboratories Limited To Conduct EGMBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Meeting To Be Held On Thursday, April 16, 2026BSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And Nomination And Remuneration Committee Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015BSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Quarter And Nine Months Ended December 31, 2025BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2025BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Gennex Laboratories Ltd - 531739 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Gennex Laboratories Ltd - 531739 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing